Plasma adenosine levels increase in patients with chronic heart failure

Circulation

Volumn 95, Issue 6, 1997, Pages 1363-1365

  Funaya, Hiroharu ^a   Kitakaze, Masafumi ^a   Node, Koichi ^a   Minamino, Tetsuo ^a   Komamura, Kazuo ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

adenosine; enzymes; heart failure; norepinephrine

Indexed keywords

ADENOSINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0030934868     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.6.1363     Document Type: Article

References (13)

1. Packer M. Neurohumoral interactions and adaptation in congestive heart failure. Circulation. 1988;77:721-730.
2. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin E. Effects of chronic ß-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022-1036.
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
4. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
5. Savic V, Stefanovic V, Ardaillou N, Ardaillou R. Induction of ecto-5'-nucleotidase of rat cultured mesangial cells by interleukin-1β and tumor necrosis factor-α. Immunology. 1990;70: 321-326.
6. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574. Brief Review.
7. Kitakaze M, Hori M, Kamada T. The role of adenosine and its interaction with alpha-adrenoceptor activity in myocardial ischemie and reperfusion injury. Cardiovasc Res. 1993;27:18-27. Brief Review.
8. Lagerkranser N, Sollevi A, Irestedt L, Tidgren B, Andreen M. Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in the dog. Acta Anaesthesiol Scand. 1985;29:45-49.
9. Parmely MJ, Zhou WW, Edward CK III, Borcherding DR, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrotic factor-α production and protect mice against endotoxin challenge. J Immunol. 1993;151:389-396.
10. Yamane R, Nakamura M, Matsuura H, Ishige H, Fujimoto M. A simple and sensitive radioimmunoassay for adenosine. J Immunoassay. 1991;12:501-519.
11. 1-padrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction. Circulation. 1987;75:213-220.
12. 1-adrenoceptor activation mediates the infarct size limiting effect of ischemie preconditioning through augmentation of 5'-nucleotidase activity and adenosine release. J Clin Invest. 1994;93:2197-2205.
13. 1-Adrenoceptor activation increases ectosolic 5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 1995;91:2226-2234.